Trimethoprim potentiates valproic acid-induced Neural Tube Defects (NTDs) in mice
- 30 June 1993
- journal article
- research article
- Published by Elsevier in Reproductive Toxicology
- Vol. 7 (3) , 249-254
- https://doi.org/10.1016/0890-6238(93)90231-u
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in miceFundamental and Applied Toxicology, 1992
- Valproic acid‐induced spina bifida: A mouse modelTeratology, 1992
- Valproic Acid‐Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible MechanismsBasic & Clinical Pharmacology & Toxicology, 1991
- Verification of the fetal valproate syndrome phenotypeAmerican Journal of Medical Genetics, 1988
- IN-UTERO EXPOSURE TO VALPROATE AND NEURAL TUBE DEFECTSThe Lancet, 1986
- Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acidThe Journal of Pediatrics, 1986
- VALPROATE AND BIRTH DEFECTSThe Lancet, 1983
- EMBRYOTOXICITY TESTING OF VALPROIC ACIDThe Lancet, 1983
- A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrationsLife Sciences, 1981
- Teratogenicity of valproic acid: In vivo and in vitro investigationsTeratogenesis, Carcinogenesis, and Mutagenesis, 1981